Close Menu

NEW YORK (GenomeWeb) – NantHealth on Thursday announced it is laying off about 300 employees as part of a restructuring of its business.

The firm also reported a 17 percent drop-off year over year in revenues for the second quarter.

In a statement, the company said that the restructuring follows "a series of methodically analyzed actions, planned over the past nine months post initial public offering to focus on the business of its core competencies of artificial intelligence and be the leading cancer company driving 21st century delivery of care."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.